Therapeutic innovation: Bringing world-class care to patients

Share

By pushing our therapeutic research to the leading edge of innovation and technology, we ensure that our health care measures up to the best in the world. Major investments are helping Montreal play a leading role in health care.

Montreal is known for the quality of its state-of-the-art training and basic research. Many projects help position the city in a big way as a leader in the health care continuum.

At the heart of Université de Montréal is the Institute for Research in Immunology and Cancer (IRIC), which was created in 2003 to unravel cancer mechanisms and accelerate the discovery of new and more effective therapies against this disease.

“Industry and universities can work together and use their strengths to accelerate the transfer of knowledge towards treatment for patients,” says Michel Bouvier, Chief Executive Officer of IRIC and Deputy Vice-Rector of Research, Discovery, Creation and Innovation at Université de Montréal.

Launched by Polytechnique Montréal, the TransMedTech Institute shapes technologies that help doctors make diagnoses and prognoses for complex diseases. To fight these diseases, the institute is developing the next generation of procedures and technologies.

With its research activities and graduate programs, which are supported by many donations, the School of Optometry advances knowledge in the science of sight and contributes to the development of vision technologies.

Many areas of health care are reaping the benefits of burgeoning activity at Campus Montréal.

Benefits

  • Streamline the health care experience. The Pôle santé health care platform provides complementarity between expertise from universities and health networks.
  • Create a continuum from basic research to (applied) clinical research.
  • Optimize treatment and tackle challenges that so far have been unsolvable.
  • Contribute to discoveries that could change the way we treat specific diseases.

Financial support means concrete benefits

“Philanthropy can really make a difference. It allows us to quickly make projects a reality. It has a significant impact on innovations that will transform people’s lives,” explains Carl-Éric Aubin, a professor in the Department of Mechanical Engineering at Polytechnique Montréal and Director of the TransMedTech Institute.

More than just a generous act, a donation to support therapeutic innovations is a way for donors to help create a better world.

This is why the Fondation Marcel et Rolande Gosselin made a $500,000 donation to the IRIC’s chemical compound library, which helps researchers design new drugs. Élaine and Réal Raymond also contributed to IRIC research with a donation of $100,000, while the National Bank made a gift of $500,000.

The School of Optometry at Université de Montréal benefited from three donations of $100,000 from Securo Vision, OPTOPLUS, and optometrists and opticians in the Opto-Réseau network, in addition to a $500,000 donation from the Essilor Group.

“A major gift let us open a new operating room devoted exclusively to research,” continues Carl-Éric Aubin.

Montreal’s TransMedTech Institute also received federal funding of over $35.6 million from the Canada First Research Excellence Fund and received a partner contribution of $60 million.

Basic research keeps people healthy

As pioneers in health research, Campus Montréal’s three institutions build bridges between basic research and applied research. The medicine of the future is now and will help us keep the world healthy.

Other achievements

Other impact stories